XML 37 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Stockholders' Equity Note [Abstract] |
Schedule of Stock-Based Compensation Expense | The Company recorded stock-based compensation expense in the following expense categories of its condensed consolidated statements of operations (in thousands):
| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Cost of revenue | $ | 394 |  |  | $ | 383 |  |  | $ | 1,054 |  |  | $ | 1,123 |
Research, development and clinical trials expenses |  | 850 |  |  |  | 1,077 |  |  |  | 3,355 |  |  |  | 3,078 |
Selling, general and administrative expenses |  | 7,892 |  |  |  | 6,484 |  |  |  | 23,057 |  |  |  | 18,256 |
| $ | 9,136 |  |  | $ | 7,944 |  |  | $ | 27,466 |  |  | $ | 22,457 |

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration